Skip to main content

Advertisement

Table 2 Patient demographic and disease-related data and association with screening score

From: Identifying the need for specialized palliative care in adult cancer patients – development and validation of a screening procedure based on proxy assessment by physicians and filter questions

N = 208    Mean score ± SD Test/Test statistic Significance
Gender male 45.2% 7.47 ± 2.413 t-Test: t206 = 1.615 p = .108
female 54.8% 6.89 ± 2.722 p = .122
Age Years;
mean 63,47 ± 13,383
range 21–96
21–30 7.50 ± 2.121 one-way ANOVA
(groups):
F(7, 200) = 1.654
31–40 7.40 ± 1.776
41–50 8.47 ± 2.452
51–60 6.90 ± 2.564
61–70 6.91 ± 2.914
71–80 6.72 ± 2.447
81–90 8.25 ± 2.236
> 90 9.50 ± 0.707
Performance status ECOG 0 5.3% 3.09 ± 1.044 one-way ANOVA:
F(4, 203) = 120.081
p < 0.01
ECOG 1 30.8% 5.02 ± 1.386
ECOG 2 23.6% 6.78 ± 1.571
ECOG 3 19.7% 8.93 ± 1.233
ECOG 4 20.7% 10.09 ± 1.571
Primary diagnosis Bronchial carcinoma 16.3% 7.00 ± 2.807 one-way ANOVA:
F(22, 185) = 1.405
p = .166
Mammary carcinoma 14.4% 6.67 ± 2.758
Carcinoma of the female genital tract 9.1% 5.79 ± 2.149
Renal cell carcinoma 5.3% 7.36 ± 3.042
Myelomatosis 4.8% 5.70 ± 2.163
Leukemia 4.8% 6.30 ± 1.947
Colon cancer 4.3% 8.33 ± 2.179
Lymphoma 4.3% 6.56 ± 2.242
Esophageal cancer 4.3% 8.11 ± 1.453
Pancreatic carcinoma 4.3% 7.67 ± 2.598
others 28.1% 7.97 ± 2.575
Connection to PC yes 44.7% 9.27 ± 1.695 t-Test: t201 = −15.303 p < 0.01
no 52.9% 5.44 ± 1.845
missing data 2.4%  
Decease during survey yes 30.3% 8.59 ± 2.380 t-Test: t206 = −5.643 p < 0.01
no 69.7% 6.52 ± 2.441